BLEEDING IN UREMIC PATIENTS AFTER CARBENICILLIN

被引：23

作者：

ANDRASSY, K ^{[1
]}

WEISCHEDEL, E ^{[1
]}

RITZ, E ^{[1
]}

ANDRASSY, T ^{[1
]}

机构：

[1] UNIV HEIDELBERG, LUDOLF KREHL KLIN, MED KLIN, D-6900 HEIDELBERG, GERMANY

来源：

关键词：

D O I：

10.1055/s-0038-1648015

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：115 / 126

页数：12

共 43 条

[1] APPEL W, 1970, METHODEN ENZYMATISCH, P906
[2] THE FIBRIN PLATE METHOD FOR ESTIMATING FIBRINOLYTIC ACTIVITY
ASTRUP, T
MULLERTZ, S
[J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1952, 40 (02) : 346 - 351
[3] BACHMANN F, 1957, THROMB DIATH HAEMOST, V1, P169
[4] BAUER AW, 1966, AM J CLIN PATHOL, V45, P493
[5] FIBRINOGEN-FIBRIN INTERACTION
BELITSER, VA
VARETSKA.TV
MALNEVA, GV
[J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1968, 154 (02) : 367 - &
[6] Biggs R., 1962, HUMAN BLOOD COAGULAT
[7] HEMOSTATIC DEFECT PRODUCED BY CARBENICILLIN
BROWN, CH
NATELSON, EA
BRADSHAW, MW
WILLIAMS, TW
ALFREY, CP
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1974, 291 (06) : 265 - 270
[8] CAZENAVE JP, 1973, P SOC EXP BIOL MED, V142, P159
[9] CLARKE HGM, 1968, CLIN SCI, V35, P403
[10] CLAUSS A., 1957, ACTA HAEMATOL, V17, P237